Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. [electronic resource]
Producer: 19950316Description: 296-304 p. digitalISSN:- 0163-2116
- Adult
- Aminosalicylic Acids -- adverse effects
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Capsules
- Colitis, Ulcerative -- drug therapy
- Delayed-Action Preparations
- Double-Blind Method
- Female
- Humans
- Male
- Mesalamine
- Middle Aged
- Proportional Hazards Models
- Prospective Studies
- Remission Induction
- Safety
- Statistics, Nonparametric
- Substance Withdrawal Syndrome -- epidemiology
- United States
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.